cytarabine has been researched along with Bronze Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FUJIMOTO, H; HIASA, Y; HORIUCHI, N; KIMURA, S; MASUDA, K; MATSUSHITA, T; NAKAMURA, S; SHICHIJO, K; SHINOMIYA, S; TAKAHASHI, K; TAKEICHI, T; TAMAKI, Y; YAMANAKA, C | 1 |
1 other study(ies) available for cytarabine and Bronze Diabetes
Article | Year |
---|---|
Multiple hepatocellular carcinomas developed 15 months after commencement of chemotherapy for elderly acute myelogenous leukemia.
Topics: Aclarubicin; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cytarabine; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Hemochromatosis; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Time Factors | 2009 |